Anders Lasson
YOU?
Author Swipe
View article: P0930 Adalimumab is equally efficient as infliximab in achieving sustained remission in Ulcerative Colitis but inferior in patients with severe disease
P0930 Adalimumab is equally efficient as infliximab in achieving sustained remission in Ulcerative Colitis but inferior in patients with severe disease Open
Background Anti-TNF treatment with infliximab (IFX) and adalimumab (ADA) are established first-line biological therapies in patients with ulcerative colitis (UC). No head-to-head studies between the two drugs exist but meta-analysis of RCT…
View article: Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis Open
Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remis…
View article: Fecal Microbiota Dynamics During Disease Activity and Remission in Newly Diagnosed and Established Ulcerative Colitis
Fecal Microbiota Dynamics During Disease Activity and Remission in Newly Diagnosed and Established Ulcerative Colitis Open
Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remis…
View article: Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis
Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis Open
Patients with ulcerative colitis often report fatigue.
View article: Faecal secretogranin and chromogranin levels persist over time and are unrelated to disease history and outcome in patients with ulcerative colitis
Faecal secretogranin and chromogranin levels persist over time and are unrelated to disease history and outcome in patients with ulcerative colitis Open
Objectives: Chromogranins (Cg) and secretogranins (Sg) are expressed by endocrine cells and may be important for the pathophysiology of ulcerative colitis (UC). We investigated dynamics of faecal granin expression in patients with UC durin…
View article: Faecal secretogranin and chromogranin levels persist over time and are unrelated to disease history and outcome in patients with ulcerative colitis
Faecal secretogranin and chromogranin levels persist over time and are unrelated to disease history and outcome in patients with ulcerative colitis Open
Objectives: Chromogranins (Cg) and secretogranins (Sg) are expressed by endocrine cells and may be important for the pathophysiology of ulcerative colitis (UC). We investigated dynamics of faecal granin expression in patients with UC durin…
View article: Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis
Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis Open
Background Patients with ulcerative colitis often report fatigue. Objectives To investigate prevalence of and risk factors for fatigue in patients with ulcerative colitis with active disease and during deep remission. Methods In this cross…
View article: P546. Psychiatric disorder, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis
P546. Psychiatric disorder, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis Open
Background: When performed, the monitoring of ADA is generally restricted to the detection of free ADA (fADA) at trough, that is, those that are not in complex with the drug.fADA may underestimate the prevalence of ADA-positive patients.Ne…
View article: Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition Open
Anti-TNF therapy responders and non-responders display distinctly separate patterns of mucosal AMP expression and gut microbiota before treatment start. This indicates that intestinal antimicrobial/microbial composition can influence treat…